Related Experiment Video
Updated: Mar 22, 2026
Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae
Published on: May 10, 2014
The Challenges of Detecting Neutrophil CFTR
Ryan Flannery1, Rory Baird1, Debananda Gogoi1
1Department of Anaesthesia and Critical Care Medicine, Pulmonary Clinical Science, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
Background:
Cystic fibrosis (CF) is a hereditary disorder caused by mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The major causes of morbidity and mortality in CF are related to lung disease, involving neutrophil-dominated lung inflammation.
Summary:
Whether the altered inflammatory response of neutrophils in patients with CF is an intrinsic defect due to a lack of CFTR protein expression, or alternatively, exacerbated by chronic exposure to infection and inflammation, is extensively debated. Fuelling this dispute are conflicting past studies on CFTR expression by neutrophils, with opposing results described at both the gene and protein level. This is pertinent in the era of CFTR modulator therapies, with clinicians and scientists exploring the impact of different CFTR mutation classes and CFTR modulators on neutrophil function.
Key Messages:
The focus of this article was to uncover the cause for the described disparity of data on neutrophil CFTR expression, by investigating methods utilised for CFTR detection and drawing consensus on the optimal protocol for identifying CFTR protein in neutrophils.
